DK3589204T3 - Apparat og fremgangsmåde til vurdering og behandling af cellulitis - Google Patents

Apparat og fremgangsmåde til vurdering og behandling af cellulitis

Info

Publication number
DK3589204T3
DK3589204T3 DK18713447.3T DK18713447T DK3589204T3 DK 3589204 T3 DK3589204 T3 DK 3589204T3 DK 18713447 T DK18713447 T DK 18713447T DK 3589204 T3 DK3589204 T3 DK 3589204T3
Authority
DK
Denmark
Prior art keywords
assessing
treating cellulitis
cellulitis
treating
Prior art date
Application number
DK18713447.3T
Other languages
English (en)
Inventor
Genzhou Liu
Jeffrey Davidson
Michael Mclane
Original Assignee
Endo Operations Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Endo Operations Ltd filed Critical Endo Operations Ltd
Application granted granted Critical
Publication of DK3589204T3 publication Critical patent/DK3589204T3/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B5/00—Measuring for diagnostic purposes; Identification of persons
    • A61B5/103—Measuring devices for testing the shape, pattern, colour, size or movement of the body or parts thereof, for diagnostic purposes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B5/00—Measuring for diagnostic purposes; Identification of persons
    • A61B5/44—Detecting, measuring or recording for evaluating the integumentary system, e.g. skin, hair or nails
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B5/00—Measuring for diagnostic purposes; Identification of persons
    • A61B5/44—Detecting, measuring or recording for evaluating the integumentary system, e.g. skin, hair or nails
    • A61B5/441—Skin evaluation, e.g. for skin disorder diagnosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B5/00—Measuring for diagnostic purposes; Identification of persons
    • A61B5/44—Detecting, measuring or recording for evaluating the integumentary system, e.g. skin, hair or nails
    • A61B5/441—Skin evaluation, e.g. for skin disorder diagnosis
    • A61B5/444—Evaluating skin marks, e.g. mole, nevi, tumour, scar
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B5/00—Measuring for diagnostic purposes; Identification of persons
    • A61B5/48—Other medical applications
    • A61B5/4848—Monitoring or testing the effects of treatment, e.g. of medication
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/43—Enzymes; Proenzymes; Derivatives thereof
    • A61K38/46—Hydrolases (3)
    • A61K38/48—Hydrolases (3) acting on peptide bonds (3.4)
    • A61K38/4886—Metalloendopeptidases (3.4.24), e.g. collagenase
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/64—Proteins; Peptides; Derivatives or degradation products thereof
    • A61K8/66—Enzymes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A61Q19/06—Preparations for care of the skin for countering cellulitis
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Y—ENZYMES
    • C12Y304/00—Hydrolases acting on peptide bonds, i.e. peptidases (3.4)
    • C12Y304/24—Metalloendopeptidases (3.4.24)
    • C12Y304/24003—Microbial collagenase (3.4.24.3)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B5/00—Measuring for diagnostic purposes; Identification of persons
    • A61B5/103—Measuring devices for testing the shape, pattern, colour, size or movement of the body or parts thereof, for diagnostic purposes
    • A61B5/107—Measuring physical dimensions, e.g. size of the entire body or parts thereof
    • A61B5/1079—Measuring physical dimensions, e.g. size of the entire body or parts thereof using optical or photographic means

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Physics & Mathematics (AREA)
  • Biophysics (AREA)
  • Pathology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Medical Informatics (AREA)
  • Molecular Biology (AREA)
  • Surgery (AREA)
  • Chemical & Material Sciences (AREA)
  • Dermatology (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Dentistry (AREA)
  • Oral & Maxillofacial Surgery (AREA)
  • Genetics & Genomics (AREA)
  • Birds (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Biochemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Immunology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Measuring And Recording Apparatus For Diagnosis (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Measurement Of The Respiration, Hearing Ability, Form, And Blood Characteristics Of Living Organisms (AREA)
DK18713447.3T 2017-03-01 2018-03-01 Apparat og fremgangsmåde til vurdering og behandling af cellulitis DK3589204T3 (da)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US201762465622P 2017-03-01 2017-03-01
US201762485705P 2017-04-14 2017-04-14
US201762607188P 2017-12-18 2017-12-18
PCT/US2018/020551 WO2018160905A1 (en) 2017-03-01 2018-03-01 Apparatus and method for assessing and treating cellulite

Publications (1)

Publication Number Publication Date
DK3589204T3 true DK3589204T3 (da) 2025-06-30

Family

ID=61768443

Family Applications (1)

Application Number Title Priority Date Filing Date
DK18713447.3T DK3589204T3 (da) 2017-03-01 2018-03-01 Apparat og fremgangsmåde til vurdering og behandling af cellulitis

Country Status (17)

Country Link
US (4) US11123280B2 (da)
EP (2) EP4591945A3 (da)
JP (3) JP7558654B2 (da)
KR (3) KR102610801B1 (da)
CN (2) CN110545722B (da)
AU (4) AU2018226820B2 (da)
BR (1) BR112019018277A2 (da)
CA (1) CA3055041A1 (da)
DK (1) DK3589204T3 (da)
ES (1) ES3036011T3 (da)
FI (1) FI3589204T3 (da)
HU (1) HUE072115T2 (da)
IL (3) IL301796A (da)
MX (2) MX2023008072A (da)
PL (1) PL3589204T3 (da)
PT (1) PT3589204T (da)
WO (1) WO2018160905A1 (da)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP4772625A2 (en) 2012-01-12 2026-07-08 Endo Biologics Limited Clostridium histolyticum enzyme
DK3589204T3 (da) 2017-03-01 2025-06-30 Endo Operations Ltd Apparat og fremgangsmåde til vurdering og behandling af cellulitis
KR20250171475A (ko) 2017-03-28 2025-12-08 엔도 오퍼레이션즈 리미티드 개선된 콜라게나제 생성 방법
WO2020021330A2 (en) 2018-07-12 2020-01-30 Endo Global Aesthetics Limited Injection techniques for the treatment of cellulite
CA3112437A1 (en) 2018-09-18 2020-03-26 Endo Global Aesthetics Limited Compositions and methods for treating cellulite
MX2021008017A (es) * 2019-01-06 2021-08-05 Endo Global Aesthetics Ltd Formulaciones de colagenasa y metodos de produccion de las mismas.
US11432733B2 (en) 2019-03-13 2022-09-06 Blossom Innovations Tissue detection devices, systems and methods
US20220095925A1 (en) 2019-03-13 2022-03-31 Blossom Innovations, LLC Devices, systems and methods for tissue analysis, location determination and therapy thereof using optical radiation
EP4417120A3 (en) 2019-03-13 2024-11-06 Blossoms Innovations, Llc Devices, systems and methods for tissue analysis, location determination and therapy thereof using optical radiation
CA3163236A1 (en) 2019-11-27 2021-06-03 Blossom Innovations, LLC Devices, systems and methods for tissue analysis, location determination and tissue ablation
WO2021150478A1 (en) 2020-01-21 2021-07-29 Nc8, Inc. Systems for improving the appearance of tissue
CN113033528A (zh) * 2021-05-27 2021-06-25 明品云(北京)数据科技有限公司 一种反馈量表评估方法、系统、设备和介质

Family Cites Families (107)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3821364A (en) 1966-07-08 1974-06-28 Advance Biofactures Corp Process of producing collagenase
JPS5662229A (en) 1979-10-25 1981-05-28 Asahi Glass Co Ltd Electro-optical dimming panel
US4338300A (en) 1981-02-05 1982-07-06 The Regents Of The University Of California Use of purified clostridial collangenase in the treatment of Peyronie's disease
CA1227132A (fr) 1983-01-05 1987-09-22 Robert J. Weill Preparation a activite collagenolytique ayant une activite elevee et compositions pharmaceutiques la contenant
US4524065A (en) 1983-08-04 1985-06-18 Bio-Specifics N.V. Method for the prevention and treatment of scars with enzymes
US4645668A (en) 1983-08-04 1987-02-24 Biospecifics, Nv Method for the prevention and treatment of scars with enzymes
US5252461A (en) 1990-05-01 1993-10-12 The Regents Of The Univ. Of California Mixed immunoglobulins for detection of rheumatoid factors
CA2047306A1 (en) 1990-07-23 1992-01-24 Milan Holjevac Mutant bacterium clostridium histolyticum, a process for the obtaining thereof, and its use in the production of clostripain-free collagenase
US5393792A (en) 1991-11-20 1995-02-28 Advance Biofactures Of Curacao, N.V. High dosage topical forms of collagenase
US5462739A (en) 1991-11-21 1995-10-31 Yeda Research And Development Co., Ltd. Microdelivery device and method for enhanced drug administration to the eye
US5256140A (en) 1992-03-27 1993-10-26 Fallien Cosmeceuticals, Ltd. Composition for levelling skin
WO1994000580A1 (en) 1992-06-22 1994-01-06 Trigen, Inc. Molecular cloning of the genes reponsible for collagenase production from clostridium histolyticum
JP3186881B2 (ja) 1993-02-18 2001-07-11 倉敷紡績株式会社 肝細胞の分離方法
US5332503A (en) 1993-04-16 1994-07-26 Baxter International Inc. Process for purifying collagenase
US5514340A (en) 1994-01-24 1996-05-07 Magnetix Biotechnology, Inc. Device for separating magnetically labelled cells
JP3028852B2 (ja) 1994-06-24 2000-04-04 ロシュ ダイアグノスティックス コーポレーション ヒストリチクス菌から得られるコラゲナーゼおよび2つの他のプロテアーゼの精製混合物
US5589171A (en) 1994-08-22 1996-12-31 Advance Biofactures Of Curacao Treatment of Dupuytren's disease with collagenase
CA2158822C (en) 1994-09-27 2008-12-23 Kusuki Nishioka Therapeutic agent for rheumatic disease
US6958150B2 (en) 1994-12-15 2005-10-25 Advance Biofactures Of Curacao, N.V. Reduction of adipose tissue
BR9607143A (pt) 1995-03-16 1997-11-25 Knoll Ag Enzima ibtenível de clostridium histolyticum mistura de enzimas uso da mistura uso de enzimas colagenase hp na forma pura colagenase az na forma pura e elastase na forma pura
IT1279011B1 (it) 1995-06-15 1997-12-02 Ips Int Prod Services Apparecchiatura per la rilevazione e scelta dei trattamenti della cellulite
US5705170A (en) * 1995-10-24 1998-01-06 Plantech International, Inc. Herbal cellulite treatments
US5989888A (en) 1996-01-24 1999-11-23 Roche Diagnostics Corporation Purified mixture of collagenase I, collagenase II and two other proteases
WO1998022574A2 (de) 1996-11-19 1998-05-28 Roche Diagnostics Gmbh Rekombinante collagenase typ i aus clostridium histolyticum und ihre verwendung zur isolierung von zellen und zellverbänden
US5830741A (en) 1996-12-06 1998-11-03 Boehringer Mannheim Corporation Composition for tissue dissociation containing collagenase I and II from clostridium histolyticum and a neutral protease
US5753785A (en) 1996-12-16 1998-05-19 Fina Technology, Inc. Production of E-B copolymers with a single metallocene catalyst and a single monomer
US6086872A (en) 1997-03-27 2000-07-11 Advance Biofactures Of Curacao, Nv Amelioration of dupuytren's disease
JPH10262658A (ja) 1997-03-28 1998-10-06 Kikkoman Corp ザルコシン・オキシダーゼの結晶、その製造方法及び三次元構造
US6335388B1 (en) 1997-10-03 2002-01-01 Lavipharm Laboratories Inc. Prolamine-plant polar lipid composition, its method of preparation and applications thereof
GB9724802D0 (en) 1997-11-24 1998-01-21 Unilever Plc Antiperspirant or deodorant compoistions
US20020036328A1 (en) 1998-11-16 2002-03-28 William R. Richards, Jr. Offset drain fermi-threshold field effect transistors
FR2788682B1 (fr) * 1999-01-26 2001-04-06 Seb Sa Dispositif de thermographie
US6022539A (en) 1999-06-03 2000-02-08 Advance Biofactures Of Curacao Amelioration of peyronie's disease
RU2180002C2 (ru) 1999-08-16 2002-02-27 Пермское научно-производственное объединение "Биомед" Способ получения коллагеназы
EP1207840B1 (en) 1999-08-20 2004-10-13 Howard Murad Pharmaceutical compositions and methods for reducing the appearance of cellulite
US6280993B1 (en) 1999-08-24 2001-08-28 Ichiro Yamato Gene encoding class I collagenase
ITMI991894A1 (it) * 1999-09-09 2001-03-09 Carlo Ghisalberti Acido linoleico coniugato e trigliceride nuovi metodi di sintesi e d'uso
PT1220830E (pt) 1999-09-24 2007-06-11 Proteon Therapeutics Inc Utilização de elastase para abertura de artérias e veias obstruídas
AU4477001A (en) 2000-04-18 2001-10-30 Peptron Inc. Injectable sustained release pharmaceutical composition and processes for preparing the same
DK1355566T3 (da) 2000-12-18 2013-03-04 Univ Texas Lokal regional kemoterapi og radioterapi ved anvendelse af hydrogel in situ
US20030022856A1 (en) 2001-01-30 2003-01-30 The Regents Of The University Of Michigan Method for sustained release local delivery of drugs for ablation of unwanted tissue
CA2447818C (en) 2001-07-02 2011-01-04 Nordmark Arzneimittel Gmbh & Co. Kg Method for purifying an enzyme and purified enzyme produced according to this method, as well as use of the enzyme
GB0124124D0 (en) 2001-10-08 2001-11-28 Medical Res Council Methods of treatment
CN102018591A (zh) * 2002-03-15 2011-04-20 总医院公司 通过受控冷却对脂肪组织进行选择性破坏的方法和装置
JP2003284553A (ja) 2002-03-28 2003-10-07 Seikagaku Kogyo Co Ltd 生理活性タンパク質
EP1538980B1 (en) * 2002-06-25 2017-01-18 Ultrashape Ltd. Device for body aesthetics
EP1433845A1 (en) 2002-12-23 2004-06-30 Georg-August-Universität Clostridium tetani collagenase and uses thereof
EP1462519A1 (en) 2003-03-24 2004-09-29 Boehringer Ingelheim Austria GmbH Method and devices for producing biomolecules
JP4205496B2 (ja) 2003-06-19 2009-01-07 三菱化学株式会社 新規カルボニル還元酵素及びこれをコードするdna、ならびにこれらを利用した光学活性アルコールの製造方法
NZ576986A (en) 2004-01-30 2010-12-24 Shire Pharmaceuticals Ireland Ltd Production and purification of recombinant arylsulfatase A
US8147428B2 (en) * 2004-04-16 2012-04-03 University Of Massachusetts Device and method for quantifying edema
ES2372499T3 (es) 2004-05-19 2012-01-20 Los Angeles Biomedical Research Institute At Harbor-Ucla Medical Center Uso de un detergente para la eliminación no quirúrgica de grasa.
US7754230B2 (en) * 2004-05-19 2010-07-13 The Regents Of The University Of California Methods and related compositions for reduction of fat
US7355027B2 (en) 2004-06-16 2008-04-08 Dynport Vaccine Company Llc Bacillus anthracis protective antigen
EP1781697B1 (en) 2004-07-07 2009-04-22 H.Lundbeck A/S Novel carbamylated epo and method for its production
EP1773400A2 (en) 2004-07-08 2007-04-18 Amgen Inc. Therapeutic peptides
JP4976131B2 (ja) 2004-08-30 2012-07-18 株式会社ダイセル ポリグリセリンモノエーテル及びその製造方法
US20150025420A1 (en) * 2004-10-06 2015-01-22 Guided Therapy Systems, Llc Ultrasound treatment device and methods of use
DE102004060075A1 (de) 2004-12-14 2006-07-06 Merck Patent Gmbh Verfahren zur Herstellung von Onium-Salzen mit Dialkylphosphat-, Dialkylphosphinat oder (O-Alkyl)-alkyl- oder Alkyl-phosphonat-Anionen mit geringem Halogenid-Gehalt
US20060204488A1 (en) 2005-01-21 2006-09-14 Badalamente Marie A Methods for treating adhesive capsulitis
US7854929B2 (en) 2005-01-21 2010-12-21 The Research Foundation Of State University Of New York Method for treating lateral epicondylitis using collagenase
US20070224184A1 (en) * 2006-02-22 2007-09-27 The Research Foundation Of The State University Of New York Method for treating cellulite
JP2006254876A (ja) 2005-03-18 2006-09-28 Hokkaido Univ L−トリプトファン製造法
US20060251581A1 (en) 2005-05-09 2006-11-09 Mcintyre Jon T Method for treatment of uterine fibroid tumors
US20070003541A1 (en) 2005-07-01 2007-01-04 Rodolfo Faudoa Methods and compositions for therapeutics
ITPD20050207A1 (it) 2005-07-07 2007-01-08 Fidia Farmaceutici Nuove composizioni farmaceutiche contenenti acido ialuronico e collagenas nel trattamento topico di ferite, ustioni ed ulcere
US20070031482A1 (en) * 2005-08-02 2007-02-08 Ceramoptec Industries, Ind. PDT treatment method for cellulites and cosmetic use
JP3122177U (ja) * 2005-09-28 2006-06-08 株式会社資生堂 セルライトの診断基準シート
US7811560B2 (en) 2006-01-30 2010-10-12 Auxilium Us Holdings, Llc Compositions and methods for treating collagen-mediated diseases
WO2007100590A2 (en) * 2006-02-22 2007-09-07 Auxilium Pharmaceuticals, Inc. Methods for treating cellulite
EP2001561A2 (en) * 2006-03-31 2008-12-17 DSMIP Assets B.V. Novel use of compounds and combinations of compunds for improving the physical appearance
US20080233614A1 (en) 2007-02-13 2008-09-25 Cranenburgh Rocky M Production of recombinant collagenases colg and colh in escherichia coli
WO2008101406A1 (en) 2007-02-14 2008-08-28 Yolare Dermaceuticals, Llc Modified mutant collagenase and it's use in fat melting and in scar reduction
CN101677912B (zh) * 2007-05-11 2013-06-12 希格马托制药工业公司 可用于递送化妆品活性成分的凝胶
US9987221B2 (en) 2007-08-23 2018-06-05 Boston Scientific Scimed, Inc. Injectable hydrogel compositions
EP2217614A4 (en) 2007-11-07 2011-12-07 Dynamic Microbials Ltd ANTIMICROBIAL COMPOSITIONS, FORMULATIONS AND APPLICATIONS THEREOF
US20100159564A1 (en) 2007-11-30 2010-06-24 Dwulet Francis E Protease resistant recombinant bacterial collagenases
EP2130551B1 (en) 2008-06-02 2012-06-06 Roche Diagnostics GmbH Improved purification of collagenases from clostridium histolyticum liquid culture
US8236356B2 (en) 2008-06-11 2012-08-07 Roche Diagnostics Operations, Inc. Growth medium for Clostridium histolyticum
WO2010011605A2 (en) 2008-07-21 2010-01-28 Otonomy, Inc. Controlled-release otic structure modulating and innate immune system modulating compositions and methods for the treatment of otic disorders
US8380531B2 (en) 2008-07-25 2013-02-19 Invivodata, Inc. Clinical trial endpoint development process
EP2369956A1 (en) * 2008-10-22 2011-10-05 Allergan, Inc. Clinical assessment scales and methods
JP2012508267A (ja) * 2008-11-11 2012-04-05 シグマ−タウ・インドゥストリエ・ファルマチェウチケ・リウニテ・ソシエタ・ペル・アチオニ セルライトの処置に有用な化合物
AU2009318554B2 (en) 2008-11-19 2016-06-09 Meiji Seika Pharma Co. Ltd. Fusion collagenase to which affinity tag is attached, and method for producing same
IT1397646B1 (it) 2009-12-15 2013-01-18 Seidita Collagenasi ricombinanti di c. histolyticum e metodo per la loro produzione.
US9132199B2 (en) 2010-03-05 2015-09-15 University of Pittsburgh—of the Commonwealth System of Higher Education Reverse thermal gels and uses therefor
US20130195828A1 (en) 2010-04-14 2013-08-01 Northwestern University Pharmaceutical Compositions and Methods for Digesting Atherosclerotic Plaques
WO2012024635A2 (en) * 2010-08-19 2012-02-23 Medicis Pharmaceutical Corporation Mid-face aesthetic scale and related methods
US20130217789A1 (en) 2010-09-03 2013-08-22 North Carolina Central University Biodegradable liquogel and ph sensitive nanocarriers
ES2385239B1 (es) 2010-09-30 2013-06-19 Proteos Biotech S.L.U. Uso de colagenasa g recombinante, colagenasa h recombinante y pz-peptidasa recombinante para el tratamiento de enfermedades que cursan con alteraciones del colágeno.
US20120237492A1 (en) * 2011-02-18 2012-09-20 Kythera Biopharmaceuticals, Inc. Treatment of submental fat
US10119131B2 (en) * 2011-03-16 2018-11-06 Biospecifics Technologies Corp. Compositions and methods for producing clostridial collagenases
TWI461214B (zh) 2011-06-13 2014-11-21 Univ Chang Gung Biodegradable water-sensitive glue, a drug delivery system as a carrier thereof, and a pharmaceutical composition for the treatment and / or prevention of eye diseases
KR102043476B1 (ko) * 2011-10-17 2019-11-12 사운드 써지칼 테크놀로지 엘엘씨 셀룰라이트를 처리하기 위한 초음파 프로브
JP2014530873A (ja) * 2011-10-21 2014-11-20 オーキシリウム インターナショナル ホールディングス,インコーポレイテッド Efpの治療または低減方法
EP4772625A2 (en) 2012-01-12 2026-07-08 Endo Biologics Limited Clostridium histolyticum enzyme
MX2014009083A (es) * 2012-01-27 2015-07-17 Revance Therapeutics Inc Metodos y escalas de evaluacion para la medicion de la gravedad de las arrugas.
US9933436B2 (en) * 2012-09-07 2018-04-03 Shiseido Company, Ltd. Method of evaluating cellulite and method of evaluating cellulite-effective drug using fibulin-3 and/or sarcoglycan gamma as an indicator
US20160000890A1 (en) 2013-03-15 2016-01-07 Biospecifics Technologies Corp. Thermosensitive hydrogel collagenase formulations
WO2014150545A1 (en) * 2013-03-15 2014-09-25 Mary Kay Inc. Cosmetic compositions and uses thereof
WO2014144859A1 (en) 2013-03-15 2014-09-18 Biospecifics Technologies Corporation Treatment method and product for uterine fibroids using purified collagenase
CN103751102A (zh) 2014-01-15 2014-04-30 上海交通大学 一种胶原酶温敏水凝胶及其制备方法和应用
BR112016030341A8 (pt) * 2014-06-27 2021-07-20 Medytox Inc formulação para a remoção não cirúrgica de um depósito de gordura localizada em um indivíduo, método para a remoção não cirúrgica de depósitos de gordura localizada em um indivíduo que tem acúmulo de gordura localizada, e kit
AU2017218522A1 (en) 2016-02-08 2018-08-23 OutcomeMD, Inc. Determining a wellness, improvement, or effectiveness score
ES2886651T3 (es) * 2016-10-28 2021-12-20 Merz Pharma Gmbh & Co Kgaa Tratamiento cosmético de la celulitis
DK3589204T3 (da) 2017-03-01 2025-06-30 Endo Operations Ltd Apparat og fremgangsmåde til vurdering og behandling af cellulitis
KR20250171475A (ko) 2017-03-28 2025-12-08 엔도 오퍼레이션즈 리미티드 개선된 콜라게나제 생성 방법

Also Published As

Publication number Publication date
AU2025206433A1 (en) 2025-08-07
ES3036011T3 (en) 2025-09-11
CA3055041A1 (en) 2018-09-07
IL327169A (en) 2026-05-01
KR102610801B1 (ko) 2023-12-05
US20240041744A1 (en) 2024-02-08
PL3589204T3 (pl) 2025-08-11
PT3589204T (pt) 2025-07-18
CN110545722B (zh) 2023-02-03
AU2018226820A1 (en) 2019-09-19
US11123280B2 (en) 2021-09-21
FI3589204T3 (fi) 2025-07-03
EP3589204B1 (en) 2025-04-16
IL301796A (en) 2023-05-01
JP2020511284A (ja) 2020-04-16
CN115969318A (zh) 2023-04-18
US20180250217A1 (en) 2018-09-06
US20250352450A1 (en) 2025-11-20
JP2026074227A (ja) 2026-05-01
AU2024201429B2 (en) 2025-04-24
HUE072115T2 (hu) 2025-10-28
WO2018160905A1 (en) 2018-09-07
KR20250021648A (ko) 2025-02-13
IL268985A (en) 2019-10-31
JP2023120246A (ja) 2023-08-29
US11813347B2 (en) 2023-11-14
KR20190126341A (ko) 2019-11-11
AU2022271390A1 (en) 2022-12-15
US12403081B2 (en) 2025-09-02
EP4591945A2 (en) 2025-07-30
AU2024201429A1 (en) 2024-03-21
EP3589204A1 (en) 2020-01-08
US20210386644A1 (en) 2021-12-16
MX2023008072A (es) 2023-07-17
CN110545722A (zh) 2019-12-06
AU2022271390B2 (en) 2024-01-18
EP4591945A3 (en) 2026-04-15
JP7558654B2 (ja) 2024-10-01
NZ756787A (en) 2025-08-29
MX2023015506A (es) 2024-01-22
BR112019018277A2 (pt) 2020-06-30
AU2018226820B2 (en) 2022-12-08
KR20230003601A (ko) 2023-01-06

Similar Documents

Publication Publication Date Title
DK3677032T3 (da) Fremgangsmåde og apparat til kodning
DK3265757T3 (da) Fremgangsmåde og apparat til optisk detektion
DK3975559T3 (da) Fremgangsmåde og apparat til kodning/afkodning af billeddata
DK4191179T3 (da) Apparat og fremgangsmåde til sprøjtetørring
DK3703542T3 (da) Apparat og fremgangsmåde til brygning af infusionsmateriale
DK4358029T3 (da) Apparat og fremgangsmåde til behandling og udførelse af strålesporingsinstruktioner
DK3657749T3 (da) Fremgangsmåde til transmission af he-ltf-sekvens og apparat
DK3423711T3 (da) Fremgangsmåde og apparat til vejning af en langstrakt genstand
DK3259082T3 (da) Apparat og fremgangsmåde til tilførsel af stænger
DK3507416T3 (da) Proces og apparat til vådlægning af ikkevævede
DK3446283T3 (da) Fremgangsmåde og apparat til sammenhæftning af billeder
DK3411240T3 (da) Fremgangsmåde og apparat til trykning
DK3455825T3 (da) Apparat og fremgangsmåde til brudanalyse
DK3280686T3 (da) Apparat og fremgangsmåde til forbedret damptørring
PL3589204T3 (pl) Urządzenie i sposób oceny i leczenia cellulitu
DK3554760T3 (da) Fremgangsmåder og apparat til formgivning af arbejdsstykker
DK3256300T3 (da) Apparat og fremgangsmåde til pultrusion
DK4052518T3 (da) Fremgangsmåde og apparat til sondering af adgangspunkter
DK3170479T3 (da) Apparat og fremgangsmåde til behandling af en neurologisk forstyrrelse af hørelsen
DK3468731T3 (da) Apparat og fremgangsmåde til håndtering af metalprodukter
DK3259543T3 (da) Apparat og fremgangsmåde til generering af smådråber
DK3684508T3 (da) Fremgangsmåde og apparat til reduktion af en prøves volumen
DK3472544T3 (da) Apparat og fremgangsmåde til varmebehandling af mineralsk materiale
DK3684429T3 (da) Apparat og fremgangsmåder til at forhindre biofouling
DK3301634T3 (da) Apparat og fremgangsmåde til automatisk validering-, estimering- og editering-konfiguration